Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 89 articles:
HTML format
Text format



Single Articles


    June 2018
  1. YU OM, Benitez JA, Plouffe SW, Ryback D, et al
    YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.
    Oncogene. 2018 Jun 11. pii: 10.1038/s41388-018-0301.
    PubMed     Text format     Abstract available


  2. TAN Z, Song L, Wu W, Zhou Y, et al
    TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2.
    Oncogene. 2018 Jun 4. pii: 10.1038/s41388-018-0344.
    PubMed     Text format     Abstract available


    May 2018
  3. BOETTO J, Apra C, Bielle F, Peyre M, et al
    Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0328.
    PubMed     Text format     Abstract available


  4. YU M, Li W, Wang Q, Wang Y, et al
    Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0319.
    PubMed     Text format     Abstract available


  5. ZHOU X, Li G, An S, Li WX, et al
    A new method of identifying glioblastoma subtypes and creation of corresponding animal models.
    Oncogene. 2018 May 17. pii: 10.1038/s41388-018-0305.
    PubMed     Text format     Abstract available


  6. LI N, Zhang Y, Sidlauskas K, Ellis M, et al
    Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0277.
    PubMed     Text format     Abstract available


  7. GUO X, Qiu W, Liu Q, Qian M, et al
    Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0261.
    PubMed     Text format     Abstract available


    April 2018
  8. HEUKERS R, Fan TS, de Wit RH, van Senten JR, et al
    The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0255.
    PubMed     Text format     Abstract available


  9. BEGUM S, Yiu A, Stebbing J, Castellano L, et al
    Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0230.
    PubMed     Text format     Abstract available


  10. LU J, Liu L, Zheng M, Li X, et al
    MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0249.
    PubMed     Text format     Abstract available


    March 2018
  11. JIN P, Shin SH, Chun YS, Shin HW, et al
    Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-kappaB signaling pathway.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0182.
    PubMed     Text format     Abstract available


  12. LIU YY, Chen MB, Cheng L, Zhang ZQ, et al
    microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation.
    Oncogene. 2018 Mar 9. pii: 10.1038/s41388-018-0184.
    PubMed     Text format     Abstract available


  13. ZHU ZC, Liu JW, Li K, Zheng J, et al
    KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
    Oncogene. 2018 Mar 9. pii: 10.1038/s41388-018-0180.
    PubMed     Text format     Abstract available


  14. BOLIN S, Borgenvik A, Persson CU, Sundstrom A, et al
    Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0135.
    PubMed     Text format     Abstract available


    February 2018
  15. OYINLADE O, Wei S, Lal B, Laterra J, et al
    Targeting UDP-alpha-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.
    Oncogene. 2018 Feb 26. pii: 10.1038/s41388-018-0138.
    PubMed     Text format     Abstract available


  16. CAJA L, Tzavlaki K, Dadras MS, Tan EJ, et al
    Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0136.
    PubMed     Text format     Abstract available


    January 2018
  17. ZHANG M, Huang N, Yang X, Luo J, et al
    A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0019.
    PubMed     Text format     Abstract available


  18. SUN L, Yu S, Xu H, Zheng Y, et al
    FHL2 interacts with EGFR to promote glioblastoma growth.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0068.
    PubMed     Text format     Abstract available


  19. LOSKUTOV YV, Griffin CL, Marinak KM, Bobko A, et al
    LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0049.
    PubMed     Text format     Abstract available


  20. AN Z, Aksoy O, Zheng T, Fan QW, et al
    Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0045.
    PubMed     Text format     Abstract available


    December 2017
  21. BOUSSIOTIS VA, Charest A
    Immunotherapies for malignant glioma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0024.
    PubMed     Text format     Abstract available


    November 2017
  22. ALMIRON BONNIN DA, Havrda MC, Lee MC, Liu H, et al
    Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
    Oncogene. 2017 Nov 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  23. PROVENZANO L, Ryan Y, Hilton DA, Lyons-Rimmer J, et al
    Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.
    Oncogene. 2017;36:6132-6142.
    PubMed     Text format     Abstract available


    October 2017
  24. HOLMES B, Benavides-Serrato A, Freeman RS, Landon KA, et al
    mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  25. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
    Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  26. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  27. CHEN D, Fan Z, Rauh M, Buchfelder M, et al
    ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Oncogene. 2017;36:5593-5608.
    PubMed     Text format     Abstract available


    September 2017
  28. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  29. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
    DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  30. JAIN P, Fierst TM, Han HJ, Smith TE, et al
    CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  31. GUERRERO PA, Tchaicha JH, Chen Z, Morales JE, et al
    Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    July 2017
  32. YAN D, Kowal J, Akkari L, Schuhmacher AJ, et al
    Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  33. TAYLOR E, Alqadri N, Dodgson L, Mason D, et al
    MRL proteins cooperate with activated Ras in glia to drive distinct oncogenic outcomes.
    Oncogene. 2017;36:4311-4322.
    PubMed     Text format     Abstract available


  34. RODRIGUEZ-BLANCO J, Pednekar L, Penas C, Li B, et al
    Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  35. ARSLAN AD, Sassano A, Saleiro D, Lisowski P, et al
    Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
    Oncogene. 2017 Jul 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  36. YANG JM, Schiapparelli P, Nguyen HN, Igarashi A, et al
    Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
    Oncogene. 2017;36:3673-3685.
    PubMed     Text format     Abstract available


  37. CASTRO BA, Flanigan P, Jahangiri A, Hoffman D, et al
    Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Oncogene. 2017;36:3749-3759.
    PubMed     Text format     Abstract available


  38. CONDUIT SE, Ramaswamy V, Remke M, Watkins DN, et al
    A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  39. TIAN R, Wang J, Yan H, Wu J, et al
    Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  40. KESANAKURTI D, Maddirela D, Banasavadi-Siddegowda YK, Lai TH, et al
    A novel interaction of PAK4 with PPARgamma to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  41. ZHU C, Chrifi I, Mustafa D, van der Weiden M, et al
    CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  42. ZENG AL, Yan W, Liu YW, Wang Z, et al
    Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  43. KAWAUCHI D, Ogg RJ, Liu L, Shih DJH, et al
    Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  44. WALD JH, Hatakeyama J, Printsev I, Cuevas A, et al
    Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  45. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  46. LIU YS, Lin HY, Lai SW, Huang CY, et al
    MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  47. SCHROCK MS, Batar B, Lee J, Druck T, et al
    Wwox-Brca1 interaction: role in DNA repair pathway choice.
    Oncogene. 2017;36:2215-2227.
    PubMed     Text format     Abstract available


  48. NANDHU MS, Kwiatkowska A, Bhaskaran V, Hayes J, et al
    Tumor-derived fibulin-3 activates pro-invasive NF-kappaB signaling in glioblastoma cells and their microenvironment.
    Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  49. HU PS, Xia QS, Wu F, Li DK, et al
    NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  50. DEGUCHI S, Katsushima K, Hatanaka A, Shinjo K, et al
    Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  51. QI Q, Kang SS, Zhang S, Pham C, et al
    Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  52. SHIN CH, Robinson JP, Sonnen JA, Welker AE, et al
    HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  53. NATSUME A, Kato T, Kinjo S, Enomoto A, et al
    Girdin maintains the stemness of glioblastoma stem cells.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.
    PubMed     Text format    


  54. CHEN R, Duan J, Li L, Ma Q, et al
    mTOR promotes pituitary tumor development through activation of PTTG1.
    Oncogene. 2017;36:979-988.
    PubMed     Text format     Abstract available


  55. MASILAMANI AP, Ferrarese R, Kling E, Thudi NK, et al
    KLF6 depletion promotes NF-kappaB signaling in glioblastoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  56. VOLPIN F, Casaos J, Sesen J, Mangraviti A, et al
    Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  57. SAREDDY GR, Viswanadhapalli S, Surapaneni P, Suzuki T, et al
    Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  58. GARG N, Bakhshinyan D, Venugopal C, Mahendram S, et al
    CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  59. TALAMILLO A, Grande L, Ruiz-Ontanon P, Velasquez C, et al
    ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  60. HU L, Li X, Liu Q, Xu J, et al
    UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  61. XI G, Hayes E, Lewis R, Ichi S, et al
    CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-kappaB pathway in multidrug-resistant glioblastoma cells in vitro.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format    


    August 2016
  62. HOU J, Deng Q, Zhou J, Zou J, et al
    CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
    Oncogene. 2016 Aug 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    July 2016
  63. BLANCHART A, Fernando R, Haring M, Assaife-Lopes N, et al
    Endogenous GABAA receptor activity suppresses glioma growth.
    Oncogene. 2016 Jul 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    June 2016
  64. CAI H, Liu X, Zheng J, Xue Y, et al
    Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma.
    Oncogene. 2016 Jun 27. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  65. BANASAVADI-SIDDEGOWDA YK, Russell L, Frair E, Karkhanis VA, et al
    PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  66. HUANG MY, Xuan F, Liu W, Cui HJ, et al
    MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation.
    Oncogene. 2016 Jun 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    May 2016
  67. MONDAL B, Patil V, Shwetha SD, Sravani K, et al
    Integrative functional genomic analysis identifies epigenetically regulated fibromodulin as an essential gene for glioma cell migration.
    Oncogene. 2016 May 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  68. GHOOCHANI A, Schwarz MA, Yakubov E, Engelhorn T, et al
    MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.
    Oncogene. 2016 May 9. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  69. WEN J, Lee J, Malhotra A, Nahta R, et al
    WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma.
    Oncogene. 2016 Apr 18. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  70. SHI X, Wang Q, Gu J, Xuan Z, et al
    SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  71. CAMPOS B, Olsen LR, Urup T, Poulsen HS, et al
    A comprehensive profile of recurrent glioblastoma.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  72. ELLERT-MIKLASZEWSKA A, Wisniewski P, Kijewska M, Gajdanowicz P, et al
    Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  73. ZHANG L, Zhang W, Li Y, Alvarez A, et al
    SHP-2-upregulated ZEB1 is important for PDGFRalpha-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2016
  74. LOPEZ-BERTONI H, Lal B, Michelson N, Guerrero-Cazares H, et al
    Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells.
    Oncogene. 2016 Feb 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  75. CHUA CY, Liu Y, Granberg KJ, Hu L, et al
    IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Oncogene. 2016;35:738-47.
    PubMed     Text format     Abstract available


  76. PEIXOTO P, Blomme A, Costanza B, Ronca R, et al
    HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.
    Oncogene. 2016 Feb 8. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    January 2016
  77. DEY A, Robitaille M, Remke M, Maier C, et al
    YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.
    Oncogene. 2016 Jan 4. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    November 2015
  78. AUVERGNE R, Wu C, Connell A, Au S, et al
    PAR1 inhibition suppresses the self-renewal and growth of A2B5-defined glioma progenitor cells and their derived gliomas in vivo.
    Oncogene. 2015 Nov 30. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  79. SCHULZE M, Fedorchenko O, Zink TG, Knobbe-Thomsen CB, et al
    Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.
    Oncogene. 2015 Nov 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    September 2015
  80. SARTORIUS CA, Hanna CT, Gril B, Cruz H, et al
    Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism.
    Oncogene. 2015 Sep 28. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  81. TREPS L, Edmond S, Harford-Wright E, Galan-Moya EM, et al
    Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma.
    Oncogene. 2015 Sep 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  82. GEREZ J, Tedesco L, Bonfiglio JJ, Fuertes M, et al
    RSUME inhibits VHL and regulates its tumor suppressor function.
    Oncogene. 2015;34:4855-66.
    PubMed     Text format     Abstract available


    August 2015
  83. PEREZ JG, Tran NL, Rosenblum MG, Schneider CS, et al
    The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics.
    Oncogene. 2015 Aug 24. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  84. YEN SY, Chen SR, Hsieh J, Li YS, et al
    Biodegradable interstitial release polymer loading a novel small molecule targeting Axl receptor tyrosine kinase and reducing brain tumour migration and invasion.
    Oncogene. 2015 Aug 10. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  85. LOPEZ-BERTONI H, Lal B, Li A, Caplan M, et al
    DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2.
    Oncogene. 2015;34:3994-4004.
    PubMed     Text format     Abstract available


  86. SIN WC, Aftab Q, Bechberger JF, Leung JH, et al
    Astrocytes promote glioma invasion via the gap junction protein connexin43.
    Oncogene. 2015 Jul 13. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


  87. GARCIA I, Crowther AJ, Gama V, Miller CR, et al
    Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
    Oncogene. 2015;34:3881.
    PubMed     Text format    


    June 2015
  88. AHN BY, Saldanha-Gama RF, Rahn JJ, Hao X, et al
    Glioma invasion mediated by the p75 neurotrophin receptor (p75/CD271) requires regulated interaction with PDLIM1.
    Oncogene. 2015 Jun 29. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    May 2015
  89. FRIEDMANN-MORVINSKI D, Bhargava V, Gupta S, Verma IM, et al
    Identification of therapeutic targets for glioblastoma by network analysis.
    Oncogene. 2015 May 11. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: